[Billing Code: 4140-01-P]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby
given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis
Panel NIAID Clinical Trial Planning Grants (R34); NIAID SBIR Phase II Clinical Trial
Implementation Cooperative Agreement (U44); NIAID Clinical Trial Implementation
Cooperative Agreement (U01).
Date: October 18, 2022.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases
National Institutes of Health
5601 Fishers Lane, Room 3G22
Rockville, MD 20892
(Virtual Meeting).
Contact Person: Richard G. Kostriken, PHD
Scientific Review Officer
Scientific Review Program
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
National Institutes of Health
5601 Fishers Lane, Room 3G22
Rockville, MD 20852
240-669-2075
richard.kostriken@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and
Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National
Institutes of Health, HHS.)
Dated: September 13, 2022.

Tyeshia M. Roberson-Curtis,
Program Analyst,
Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20148 Filed: 9/16/2022 8:45 am; Publication Date: 9/19/2022]